CARE Ratings Limited (NSE:CARERATING)
India · Delayed Price · Currency is INR 1,640.00
-13.10 (-0.79%)
Feb 18, 2026, 3:29 PM IST
CARE Ratings Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 4,521 | 4,023 | 3,317 | 2,790 | 2,476 | 2,484 |
| 4,521 | 4,023 | 3,317 | 2,790 | 2,476 | 2,484 | |
Revenue Growth (YoY) | 18.09% | 21.30% | 18.89% | 12.66% | -0.33% | 1.97% |
Cost of Revenue | 2,092 | 1,889 | 1,646 | 1,339 | 1,264 | 1,214 |
Gross Profit | 2,428 | 2,134 | 1,671 | 1,450 | 1,212 | 1,270 |
Selling, General & Admin | - | - | - | - | - | 28.68 |
Other Operating Expenses | 588.14 | 580.51 | 549.67 | 400.02 | 413.99 | 238.04 |
Operating Expenses | 724.22 | 697.73 | 654.5 | 505.31 | 491.05 | 390.76 |
Operating Income | 1,704 | 1,436 | 1,017 | 945.18 | 721.16 | 879.71 |
Interest Expense | -24.57 | -21.08 | -17.12 | -10.02 | -4.64 | -6.18 |
Interest & Investment Income | 457.05 | 457.05 | 428.95 | 353.66 | 254.82 | 166.12 |
Currency Exchange Gain (Loss) | 2.21 | 2.21 | 1.59 | 11.17 | - | - |
Other Non Operating Income (Expenses) | 39.5 | 4.22 | 9.94 | 8.44 | 11.19 | 14.51 |
EBT Excluding Unusual Items | 2,178 | 1,879 | 1,440 | 1,308 | 982.53 | 1,054 |
Gain (Loss) on Sale of Investments | 44.06 | 44.06 | 26.43 | 6.1 | 5.9 | 132.3 |
Asset Writedown | - | - | - | -57.06 | -2.13 | - |
Pretax Income | 2,222 | 1,923 | 1,466 | 1,257 | 986.3 | 1,186 |
Income Tax Expense | 586.11 | 522.64 | 440.66 | 402.89 | 218.01 | 276.81 |
Earnings From Continuing Operations | 1,636 | 1,400 | 1,026 | 854.58 | 768.29 | 909.66 |
Minority Interest in Earnings | -26.67 | -27.63 | -20.39 | -19.29 | -17.21 | -14.5 |
Net Income | 1,610 | 1,372 | 1,005 | 835.29 | 751.08 | 895.16 |
Net Income to Common | 1,610 | 1,372 | 1,005 | 835.29 | 751.08 | 895.16 |
Net Income Growth | 35.58% | 36.52% | 20.35% | 11.21% | -16.10% | 8.67% |
Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | 29 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | 30 |
Shares Change (YoY) | 0.24% | 0.61% | 0.68% | -0.06% | 0.56% | 0.17% |
EPS (Basic) | 53.70 | 45.89 | 33.77 | 28.17 | 25.45 | 30.38 |
EPS (Diluted) | 53.49 | 45.69 | 33.67 | 28.17 | 25.31 | 30.33 |
EPS Growth | 35.25% | 35.70% | 19.54% | 11.29% | -16.55% | 8.48% |
Free Cash Flow | - | 1,082 | 817.1 | 707.36 | 490.2 | 816.84 |
Free Cash Flow Per Share | - | 36.02 | 27.37 | 23.85 | 16.52 | 27.68 |
Dividend Per Share | - | 18.000 | 18.000 | 17.000 | 17.000 | 17.000 |
Dividend Growth | - | - | 5.88% | - | - | -12.82% |
Gross Margin | 53.72% | 53.04% | 50.38% | 51.99% | 48.95% | 51.14% |
Operating Margin | 37.70% | 35.70% | 30.65% | 33.88% | 29.12% | 35.41% |
Profit Margin | 35.60% | 34.11% | 30.31% | 29.94% | 30.33% | 36.03% |
Free Cash Flow Margin | - | 26.90% | 24.64% | 25.35% | 19.79% | 32.88% |
EBITDA | 1,768 | 1,500 | 1,081 | 1,004 | 761.21 | 920.27 |
EBITDA Margin | 39.10% | 37.28% | 32.58% | 35.97% | 30.74% | 37.04% |
D&A For EBITDA | 63.58 | 63.75 | 63.99 | 58.42 | 40.05 | 40.56 |
EBIT | 1,704 | 1,436 | 1,017 | 945.18 | 721.16 | 879.71 |
EBIT Margin | 37.70% | 35.70% | 30.65% | 33.88% | 29.12% | 35.41% |
Effective Tax Rate | 26.37% | 27.18% | 30.05% | 32.04% | 22.10% | 23.33% |
Revenue as Reported | 5,063 | 4,531 | 3,784 | 3,169 | 2,748 | 2,797 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.